| Pharmaceutical active ingredients: |
| Tamsulosin Hydrochloride |
| Available forms, composition and doses of Contiflo OD: |
| Capsules; Oral; Tamsulosin Hydrochloride 0.2 mgCapsules; Oral; Tamsulosin Hydrochloride 0.4 mg |
| Contiflo OD medical category: |
| Human:Drugs for bladder and prostate disordersSelective alfa-1-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G04CA02 - Tamsulosin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ranbaxy |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Conterra | Benzydamine Hydrochloride; Homocysteine Thiolactone Hydrochloride; Oxytetracycline | Galepharma Iberica |
| Conthel | Albendazole | Candor Biotech; Aileron Life Sciences |
| Conthram | Dantron; Poloxamer | Pacific Pharmaceuticals |
| Contiabe | Vitamin B | Cazi Quimica Farmaceutica Industria e Comercio |
| Contiflo Icon | Tamsulosin Hydrochloride | Ranbaxy |
| Contiflo-D | Dutasteride; Tamsulosin Hydrochloride | Ranbaxy |
| Contiflo-OD-F | Finasteride; Tamsulosin Hydrochloride | Sun Pharmaceutical Industries |
| Contigen | Bovine Dermal Collagen | Baxter; Bard, United Kingdom |
| Contilen | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | EMS Industria Farmaceutica |
| Conti-Marvelon | Desogestrel; Ethinyl Estradiol | Organon |